EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
146 hedge funds and large institutions have $515M invested in Eagle Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
-9
Holders Change %
-5.81%
% of All Funds
2.55%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
12
Increased
55
Reduced
53
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$14.8M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
$30.7M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
$6.42M |
| 4 |
Wells Fargo
San Francisco,
California
|
$7.44M |
| 5 |
BlackRock
New York
|
$89.1M |
